| Health / Medical Topics |
BR96-Doxorubicin Immunoconjugate
An antibody-drug conjugate composed of the chimeric monoclonal antibody BR96 chemically linked to the cytotoxic drug doxorubicin. The antibody moiety of BMS-182248-1 binds to Lewis Y, a cell surface antigen expressed on many solid tumor types. Thus, the doxorubicin conjugate is targeted specifically to Lewis Y-expressing tumor cells, where it intercalates with DNA, thereby inhibiting DNA replication and repair, RNA synthesis and protein synthesis. (NCI Thesaurus)
YOU MAY ALSO LIKE
A single-chain immunotoxin consisting of Fv fragments of the BR96 monoclonal antibody (MoAb) and a truncated Pseudomonas exotoxin (PE40) that lacking the…
The NCI term type designation for the US brand name of a drug. A brand name may be trademarked.
A substance being studied in the treatment of cancer. It is a type of antitubulin agent. Also called benzoylphenylurea.
A question associated with the BPRS-A questionnaire.
Brief Psychiatric Rating Scale-A (BPRS-A) Unusual thought content.
Brief Psychiatric Rating Scale-A (BPRS-A) Uncooperativeness.
